mesalamine has been researched along with Ileitis in 17 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Ileitis: Inflammation of any segment of the ILEUM and the ILEOCECAL VALVE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ninety-four patients with Crohn's ileitis (Crohn's Disease Activity Index [CDAI], 180-350) were randomly assigned to receive for 12 weeks mesalamine tablets, 4 g (35 patients); mesalamine microgranular preparation, 4 g (28 patients); and 6-methylprednisolone, 40 mg (31 patients)." | 9.09 | Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. ( Annese, V; Bianchi Porro, G; Cerutti, R; Cottone, M; Franzè, A; Pallone, F; Prantera, C, 1999) |
| "Ninety-four patients with Crohn's ileitis (Crohn's Disease Activity Index [CDAI], 180-350) were randomly assigned to receive for 12 weeks mesalamine tablets, 4 g (35 patients); mesalamine microgranular preparation, 4 g (28 patients); and 6-methylprednisolone, 40 mg (31 patients)." | 5.09 | Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. ( Annese, V; Bianchi Porro, G; Cerutti, R; Cottone, M; Franzè, A; Pallone, F; Prantera, C, 1999) |
| "The effects of 5-aminosalicylic acid (5-ASA), 4-ASA, N-acetyl-5-ASA, and sulfapyridine on mucosal permeability were determined in an experimental model of acute ileitis." | 3.67 | Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum. ( Granger, DN; Grisham, MB; von Ritter, C, 1989) |
| "In patients with Crohn's colitis or ileocolitis, or in those with ileitis, no statistically significant differences were noted with respect to the relapse rates between the 5-ASA and the placebo treatment groups." | 2.68 | Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease. ( Adler, M; Bailey, RJ; Rachmilewitz, D; Thomson, AB; Vatn, M; Wilson-Lynch, KA; Wright, JP, 1995) |
| "The incidence of PPI in patients with ulcerative colitis/indeterminate colitis is 5." | 1.35 | Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. ( Bell, AJ; Ciclitira, PJ; Clark, SK; McLaughlin, SD; Nicholls, RJ; Tekkis, PP, 2009) |
| "Recurrence of Crohn's disease quite inevitably occurs after resection of distal small bowel and proximal colon, involving the neoterminal ileum close to the anastomosis." | 1.31 | Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. ( Andreoli, A; Annese, V; Caprilli, R; Comberlato, M; Corrao, G; Frieri, G; Palumbo, G; Pimpo, MT; Sturniolo, GC; Tonelli, F, 2000) |
| "Relapse was defined by CD Activity Index > or = 150, CD Endoscopic Index of Severity > or =4, and by an abnormal increase of C-reactive protein, white blood cell count, and erythrocyte sedimentation rate; moreover, if it was confirmed by x-ray and/or endoscopy." | 1.31 | Does the initial location of Crohn's disease have an influence on the time-to-relapse in patients under maintenance treatment with oral mesalamine? ( Bertoni, M; Bresci, G; Capria, A; Masolino, P; Parisi, G; Scatena, F, 2000) |
| "Treatment with hydroxyurea was effective in lowering the thrombocyte count." | 1.30 | [Clinical decision making in family practice. A patient with abdominal pain and chills]. ( de Meijer, PH; Meinders, AE; Schippers, EF, 1998) |
| "Crohn's recurrence is the appearance of objective signs--defined radiologically, endoscopically or pathologically--of Crohn's disease in the bowel of a patient who has previously had a resection of all macroscopically diseased tissue." | 1.29 | Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible? ( Rutgeerts, P, 1994) |
| "A patient with chronic Reiter's syndrome (RS) refractory to nonsteroidal antiinflammatory therapy was prescribed mesalamine (Pentasa) therapy for a 4-month trial." | 1.29 | Mesalamine therapy in Reiter's syndrome. ( Inman, RD; McKibbon, C; Thomson, GT, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busoni, VB | 1 |
| Lemale, J | 1 |
| Dubern, B | 1 |
| Frangi, F | 1 |
| Bourgeois, P | 1 |
| Orsi, M | 1 |
| Badens, C | 1 |
| Fabre, A | 1 |
| Requena, P | 1 |
| Daddaoua, A | 1 |
| Martínez-Plata, E | 1 |
| González, M | 1 |
| Zarzuelo, A | 1 |
| Suárez, MD | 1 |
| Sánchez de Medina, F | 1 |
| Martínez-Augustin, O | 1 |
| McLaughlin, SD | 1 |
| Clark, SK | 1 |
| Bell, AJ | 1 |
| Tekkis, PP | 1 |
| Ciclitira, PJ | 1 |
| Nicholls, RJ | 1 |
| Tursi, A | 1 |
| Brandimarte, G | 1 |
| Giorgetti, G | 1 |
| Nasi, G | 1 |
| Prantera, C | 2 |
| Bellinvia, S | 1 |
| Kubota, D | 1 |
| Takishima, C | 1 |
| Ishii, K | 1 |
| Kawamura, T | 1 |
| Matsumoto, T | 1 |
| Itsui, Y | 1 |
| Okada, E | 1 |
| Chin, S | 1 |
| Oooka, S | 1 |
| Tsuchiya, K | 1 |
| Araki, A | 1 |
| Sakamoto, N | 1 |
| Miyata, T | 1 |
| Kanai, T | 1 |
| Watanabe, M | 1 |
| Nandi, J | 1 |
| Saud, B | 1 |
| Zinkievich, JM | 1 |
| Palma, DT | 1 |
| Levine, RA | 1 |
| Rutgeerts, P | 1 |
| Thomson, GT | 1 |
| McKibbon, C | 1 |
| Inman, RD | 1 |
| Hallak, A | 1 |
| Baratz, M | 1 |
| Santo, M | 1 |
| Halpern, Z | 1 |
| Rabau, M | 1 |
| Werbin, N | 1 |
| Gilat, T | 1 |
| Thomson, AB | 1 |
| Wright, JP | 1 |
| Vatn, M | 1 |
| Bailey, RJ | 1 |
| Rachmilewitz, D | 1 |
| Adler, M | 1 |
| Wilson-Lynch, KA | 1 |
| Schippers, EF | 1 |
| de Meijer, PH | 1 |
| Meinders, AE | 1 |
| Cottone, M | 1 |
| Pallone, F | 1 |
| Annese, V | 2 |
| Franzè, A | 1 |
| Cerutti, R | 1 |
| Bianchi Porro, G | 1 |
| Frieri, G | 1 |
| Pimpo, MT | 1 |
| Palumbo, G | 1 |
| Tonelli, F | 1 |
| Sturniolo, GC | 1 |
| Andreoli, A | 1 |
| Comberlato, M | 1 |
| Corrao, G | 1 |
| Caprilli, R | 1 |
| Bresci, G | 1 |
| Parisi, G | 1 |
| Bertoni, M | 1 |
| Masolino, P | 1 |
| Scatena, F | 1 |
| Capria, A | 1 |
| von Ritter, C | 1 |
| Grisham, MB | 1 |
| Granger, DN | 1 |
| Verhagen, PF | 1 |
| Berenschot, H | 1 |
| Breteler, L | 1 |
3 trials available for mesalamine and Ileitis
| Article | Year |
|---|---|
The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dose-Response Relationship, Drug; Double-Bli | 2005 |
Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Canada; Colitis; Crohn D | 1995 |
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Ileitis; Italy; Male; | 1999 |
14 other studies available for mesalamine and Ileitis
| Article | Year |
|---|---|
IBD-Like Features in Syndromic Diarrhea/Trichohepatoenteric Syndrome.
Topics: Anti-Inflammatory Agents; Biological Therapy; Colitis; Colon; Diarrhea; Diarrhea, Infantile; Facies; | 2017 |
Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Cattle; Disease Models, Animal; Down-Regula | 2008 |
Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Budesonide; Ciprofloxacin; Colitis, Ul | 2009 |
Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis; Crohn Disease; Delayed- | 2003 |
[A case report: Severe bone marrow suppression caused by 6-mercaptopurin in Crohn's disease patient].
Topics: Abscess; Adult; Anus Diseases; Bone Marrow; Crohn Disease; Drug Therapy, Combination; Granulocyte Co | 2006 |
5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blotting, Western; Cyclooxygenase Inhi | 2008 |
Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Crohn Disease; Humans; Ileitis; Mesalamine; Recurren | 1994 |
Mesalamine therapy in Reiter's syndrome.
Topics: Adult; Aminosalicylic Acids; Arthritis, Reactive; Colitis; Gastroenteritis; Humans; Ileitis; Male; M | 1994 |
Ileitis after colectomy for ulcerative colitis or carcinoma.
Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; | 1994 |
[Clinical decision making in family practice. A patient with abdominal pain and chills].
Topics: Abdominal Pain; Aged; Aged, 80 and over; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combi | 1998 |
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Topics: Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans | 2000 |
Does the initial location of Crohn's disease have an influence on the time-to-relapse in patients under maintenance treatment with oral mesalamine?
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Crohn Disease; Female | 2000 |
Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Dapsone; Ileitis; Intestinal Absorption; Intesti | 1989 |
[Anal disorders as the initial and only expression of Crohn's disease].
Topics: Adolescent; Adult; Aminosalicylic Acids; Anus Diseases; Crohn Disease; Female; Humans; Ileitis; Male | 1988 |